|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
16.500 -0.060 (-0.362%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 5,213,227 | 4,476,981 | 3,414,217 | 4,217,571 |
| Net Cash from / (used in) Investing Activities | -- | (2,145,767) | (3,613,323) | (3,819,290) | (4,064,038) |
| Net Cash from / (used in) Financing Activities | -- | (3,244,089) | (1,002,586) | (1,336,250) | 4,428,475 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (176,629) | (138,928) | (1,741,323) | 4,582,008 |
| Cash & Cash Equivalents at beginning of period | -- | 9,391,450 | 9,502,389 | 11,170,067 | 6,459,717 |
| Effect of Foreign Exchange Rate Changes | -- | (176,810) | 27,989 | 73,645 | 128,342 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 9,038,011 | 9,391,450 | 9,502,389 | 11,170,067 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,721,468 |
| %Change | 1.146% |
| EPS / (LPS) | RMB 0.650 |
| NBV Per Share (¥) | RMB 18.447 |